Literature DB >> 8122880

Rapidly evolving myopathy with myosin-deficient muscle fibers.

M T al-Lozi1, A Pestronk, W C Yee, N Flaris, J Cooper.   

Abstract

Five patients with rapidly evolving, severe weakness had an unusual myopathy with virtually complete loss of myosin in 5 to 40% of muscle fibers. Three of the 5 patients began to develop weakness 1 to 2 weeks after lung transplantation. The fourth became weak after a febrile illness. The fifth presented with diabetic ketoacidosis and weakness. All patients had received corticosteroid therapy. In all cases the weakness was progressive and led to severe disability, with respiratory failure in 4 patients. Initial diagnostic testing did not localize an underlying cause for the weakness. Creatine kinase was normal or minimally elevated. Electromyography generally showed mildly myopathic or nondiagnostic changes. However, muscle biopsy revealed numerous small angular fibers with no myosin ATPase staining at any pH. Immunocytochemical staining and ultrastructural studies confirmed a severe loss of myosin in many fibers. This rapidly evolving myopathy with myosin-deficient muscle fibers appears to be different clinically and pathologically from previously described syndromes involving rapidly progressive weakness. Slow recovery over a period of months is the most common outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8122880     DOI: 10.1002/ana.410350306

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting.

Authors:  D Clark Files; Franco R D'Alessio; Laura F Johnston; Priya Kesari; Neil R Aggarwal; Brian T Garibaldi; Jason R Mock; Jessica L Simmers; Antonio DeGorordo; Jared Murdoch; Monte S Willis; Cam Patterson; Clarke G Tankersley; Maria L Messi; Chun Liu; Osvaldo Delbono; J David Furlow; Sue C Bodine; Ronald D Cohn; Landon S King; Michael T Crow
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

3.  Myofibrillar protein and gene expression in acute quadriplegic myopathy.

Authors:  Holly Norman; Håkan Zackrisson; Yvette Hedström; Per Andersson; Jenny Nordquist; Lars I Eriksson; Rolf Libelius; Lars Larsson
Journal:  J Neurol Sci       Date:  2009-06-06       Impact factor: 3.181

4.  Muscle paralysis and myosin loss in a patient with cancer cachexia.

Authors:  V Banduseela; J Ochala; K Lamberg; H Kalimo; L Larsson
Journal:  Acta Myol       Date:  2007-12

Review 5.  Approach to neuromuscular disorders in the intensive care unit.

Authors:  Kenneth C Gorson
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 6.  Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19.

Authors:  Madu N Soares; Moritz Eggelbusch; Elie Naddaf; Karin H L Gerrits; Marike van der Schaaf; Bram van den Borst; W Joost Wiersinga; Michele van Vugt; Peter J M Weijs; Andrew J Murray; Rob C I Wüst
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-07       Impact factor: 12.910

7.  Uncommon presentation of a common disorder.

Authors:  P R Sowmini; M Jawahar; K Bhanu
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

8.  Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.

Authors:  Monica Llano-Diez; Guillaume Renaud; Magnus Andersson; Humberto Gonzales Marrero; Nicola Cacciani; Henrik Engquist; Rebeca Corpeño; Konstantin Artemenko; Jonas Bergquist; Lars Larsson
Journal:  Crit Care       Date:  2012-10-26       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.